Florian H. Heidel

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

Jörge E. Cortes, Florian H. Heidel, Andrzej Hellmann et al. · Leukemia · 2018 · 474 citations · Full text

Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain

Florian H. Heidel, Fian K. Solem, Frank Breitenbuecher et al. · Blood · 2005 · 265 citations

Genetic and Pharmacologic Inhibition of β-Catenin Targets Imatinib-Resistant Leukemia Stem Cells in CML

Florian H. Heidel, Lars Bullinger, Zhaohui Feng et al. · Cell stem cell · 2012 · 224 citations · Full text

Hematological Malignancy, Pharmacologic Inhibition, Medicine +7

Oncogenic JAK2 ^V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms

Alessandro Prestipino, Alica Joana Emhardt, Konrad Aumann et al. · Science Translational Medicine · 2018 · 218 citations · Full text

Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy

Thati Madhusudhan, Hongjie Wang, Wei Dong et al. · Nature Communications · 2015 · 174 citations · Full text